Acadia Pharmaceuticals | ACAD - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
ALKERMES USD 8.54M 3.59M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Cara Therapeutics USD 347K 74K 2025-03
Corcept Therapeutics USD 4.89M 537K 2026-03
Cytokinetics USD 11.02M 448K 2026-03
Eisai JPY 3.11B 783M 2024-03
Eli Lilly USD 65M 25M 2025-09
Incyte USD 38.12M 4.43M 2026-06
J&J USD 2.27 0.13 2026-06
Moderna USD 72M 2M 2026-03
Pfizer USD -0.04 115M 2026-06
Prothena USD 2.42M 935K 2026-03
Sarepta Therapeutics USD 7M 1.74M 2026-03
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06